PRKCQ inhibition enhances chemosensitivity of triple-negative breast cancer by regulating Bim

BACKGROUND: Protein kinase C theta, (PRKCQ/PKCθ) is a serine/threonine kinase that is highly expressed in a subset of triple-negative breast cancers (TNBC) and promotes their growth, anoikis resistance, epithelial-mesenchymal transition (EMT), and invasion. Here, we show that PRKCQ regulates the sen...

Descripción completa

Detalles Bibliográficos
Autores principales: Byerly, Jessica H., Port, Elisa R., Irie, Hanna Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7322866/
https://www.ncbi.nlm.nih.gov/pubmed/32600444
http://dx.doi.org/10.1186/s13058-020-01302-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7322866/
https://www.ncbi.nlm.nih.gov/pubmed/32600444
http://dx.doi.org/10.1186/s13058-020-01302-w

Ejemplares similares